References
- Eisenbarth G S. Type I diabetes mellitus: a chronic autoimmune disease. New England Journal of 1986; 314: 1360–8
- Neufeld M, Maclaren N K, Riley W J, Lezotte D, McLaughlin J V, Silverstein J, Rosenbloom A L. Islet cell antibodies in US Caucasians and blacks with insulin-dependent diabetes mellitus. Diabetes 1980; 29: 589–92
- Knight J G, Laing P, Knight A, Adams D D, Ling N. Thyroid-stimulating autoantibodies usually contain only lambda-light chains: evidence for the “forbidden clone” theory. Journal of Clinical Endocrinology and Metabolism 1986; 62: 342–7
- Adams D D, Knight J G, White P, Adams Y J, McCall J, Horrocks R, van Logheim E. A solution to the genetic and environmental puzzles of insulin-dependent diabetes mellitus. The Lancet 1984; i: 420–3
- Van Rood, Van Leeumen A, Phoem J. A method to detect simultaneously two cell populations by two-color fluorescence. Nature 1976; 262: 795–7
- Reimer C B, Phillips D J, Aloisio C H, Moore D D, Galland G G, Wells T W, Block C M, McDougal S J. Evaluation of thirty-one mouse monoclonal antibodies to human IgG epitopes. Hybridoma 1984; 3: 263–75
- Barrett D J, Ayoub E M. IgG2 subclass restriction of antibody to pneumococcal polysaccharides. Clinical and Experimental Immunology 1985; 62: 127–34
- Schatz D A, Barrett D J. Ontogeny of the subclass of IgG antibody to type 3 pneumococcal polysaccharide. Clinical and Experimental Immunology, in press
- Dean B M, Bottazzo G F, Cudworth A G. IgG subclass distribution in organ specific autoantibodies. The relationship to complement fixing ability. Clinical and Experimental Immunology 1983; 52: 61–6
- Dean B M, McNally J M, Doniach D. IgG subclass distribution of islet-cell and other organ-specific autoantibodies. Diabetologia 1980; 19: 268, abstract
- Kratsch G, Kating T, Hedderich U. Classification of islet cell antibodies assessed by paraffin sections of human pancreas. Diabetologia 1981; 21: 294, abstract
- Bruining G J, Molenaar J, Tuk C W, Lindeman J, Bruining H A, Marner B. Clinical time course and characteristics of islet cell cytoplasmic antibodies in childhood diabetes. Diabetologia 1984; 26: 24–9
- Uchigata Y, Prabhakar B S, Salata K F, Ginsberg-Fellner F, Notkins A L. Human monoclonal multiple organ-reactive autoantibodies distinguished by mouse monoclonal anti-idiotypic antibodies; expression of idiotypes in humans with and without autoimmune diseases. Journal of Immunology 1987; 138: 4218–21
- Satoh S, Prabhakar B S, Haspel M V, Ginsberg-Fellner F, Notkins A L. Human monoclonal autoantibodies that react with multiple endocrine organs. New England Journal of Medicine 1983; 309: 217–20
- Notkins A L, Prabhakar B S. Monoclonal autoantibodies that react with multiple organs; basis for reactivity. Annals of New York Academy of Sciences 1986; 475: 123–23
- Stevens R, Dieck D, Keld B, Heiner D. IgG1 is the predominant subclass of in vivo- and in vitro- produced anti-tetanus toxoid antibodies and also serves as the membrane IgG molecule for delivering inhibitory signals to anti-tetanus toxoid antibody-producing B cells. Journal of Clinical Immunology 1983; 3: 65–9
- Nayak R C, Omar M AK, Rabizadeh A, Srikanta S, Eisenbarth G A. “Cytoplasmic” islet cell antibodies. Evidence that the target antigen is a sialoglycoconjugate. Diabetes 1985; 34: 617–9
- Baekkeskov S, Nielsen J H, Marner B, Bilde T, Ludvigsson J, Lernmark A. Autoantibodies in newly diagnosed diabetic children immunoprecipitation human pancreatic islet cell proteins. Nature 1982; 298: 167–9
- Uchigata Y, Spitalnik S L, Tachiwaki O, Salata K F, Notkins A L. Pancreatic islet cell surface glycoproteins containing GalB1-4Glc NAC-R identified by a cytotoxic monoclonal autoantibody. Journal of Experimental Medicine 1987; 165: 124–9